CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.
MedPage Today on MSN
Gene-Editing Therapy Promising for Rare Hereditary Disease
A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best biotech stocks to buy. Following CRISPR Therapeutics AG ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
TwistedSifter on MSN
Pigs Modified With CRISPR Gene-Editing Technology Could Be Available For Human Consumption Very Soon
Pigs Modified With CRISPR Gene-Editing Technology Could Be Available For Human Consumption Very Soon TwistedSifter Battery ...
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
Join a full house at the Sydney Opera House with Nobel winning scientist Jennifer Doudna and Big Ideas' presenter Natasha ...
Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback